What question did this study set out to answer?

The aim is to evaluate collagen type I alpha 2 as a diagnostic and prognostic biomarker for gastric cancer.

April 3, 2026Discover Oncology0 citationsOpen Access

Collagen type I alpha 2 acts as a potential diagnostic biomarker and therapeutic targets for the prognosis in gastric cancer

JDJingjing DaiXuzhou Medical College XSXudong SongXuzhou Medical College ARAbdusemer ReyimuXuzhou Medical College

Key Points

The aim is to evaluate collagen type I alpha 2 as a diagnostic and prognostic biomarker for gastric cancer.
Identified biomarkers related to gastric cancer.
Analyzed molecular pathways involved in gastric cancer.
Assessed the potential of collagen type I alpha 2 in diagnosis and prognosis.
Collagen type I alpha 2 shows significant potential as a biomarker in gastric cancer.
Related pathways provide insights for future diagnostic approaches.

Abstract

This study reveals the potential biomarkers and related pathways of GC and provides a theoretical basis for the diagnosis and prognosis prediction of GC.

KI fragen

Bookmark

View Full Paper